SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1576Erik, Thanks for your input. This board has not had much discussion for the paw2004-6/23/2005
1575I really don't know. I don't even know if estimates have caught up with Icebrg-6/23/2005
1574Icebrg, You've been following MOGN for a long time, what do you think they&w2004-6/23/2005
1573MGI Pharma "outperform," estimates reduced Wednesday, June 22, 2005 5Icebrg-6/22/2005
1572MGI Pharma "outperform" Thursday, May 26, 2005 6:23:54 AM ET Robert WIcebrg-5/26/2005
1571MGI Pharma "outperform" Monday, May 16, 2005 6:52:13 AM ET Robert W. Icebrg-5/16/2005
1570Just a minute, here's another MOGN item. This from Ende, the other was fromtom pope-5/9/2005
1569Thanks, Erik, here's the full item for those who are interested. The analystom pope-5/9/2005
1568MGI Pharma upped at Merrill on seen Dacogen approval Monday May 9, 6:56 am ET ByIcebrg-5/9/2005
1567And they will be presenting to Baird on May 12. MINNEAPOLIS--(BUSINESS WIRE)--Mseminole-5/5/2005
1566MGI Pharma by Baird Research (22.71, April 26) Maintain Outperform/Higher Risk Jim Oravetz-5/3/2005
1565Dacogen ASCO abstracts [all poster discussions] Monday, 5/16/2005, 1:30 - 5:30zeta1961-4/25/2005
1564Simple answer. They are looking at the second trial for label expansion. The iWard Knutson-4/14/2005
1563Saforis. What struck me as rather unconventional is the way the company is handIcebrg-4/14/2005
1562MGI Pharma "outperform," estimates reduced Thursday, April 14, 2005 3Icebrg-4/14/2005
1561Board, Any comments on today's Q1 Conf call? Also, any thoughts on Dacogegfp927z-4/13/2005
1560Dacogen MOA preclinical [imho, epigenetics will positively surprise within the zeta1961-3/31/2005
1559MOGN related AACR abstracts. I think I got them all. abstractonline.com Abstrsim1-3/14/2005
1558We had an insider buyer filing today. As well as a director selling. Message 2Icebrg-2/16/2005
1557Form 8-K for MGI PHARMA INC ---------------------------------------------------A.J. Mullen-2/11/2005
1556Irofulven demonstrates clinical activity against metastatic hormone-refractory pIcebrg-2/3/2005
1555MGI Pharm Dn 11%; Generics,Medicare Cited For Rev Warning DOW JONES NEWSWIRES JJim Oravetz-1/12/2005
1554Dacogen NDA Accepted for Filing by FDA Monday January 3, 8:00 am ET MINNEAPOLISIcebrg-1/3/2005
1553That issue I follow is up again today, looking as though the "pain-in-the-aWard Knutson-12/15/2004
1552<<< They were lucky once, maybe they will be lucky again (with Dacogen)seminole-12/7/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News